Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate cancer treatment. The approval is for the 300 mg strength. The drug is a generic version of Nubeqa Tablets. The robust market potential for these tablets suggests promising future growth for Alembic.
Can Reliance Jio's fresh-issue play restore faith in India's billion-dollar IPOs?
Reliance Jio may change its IPO plan. Instead of existing investors selling shares, it could be a fresh issue. This means money goes directly into Jio Platforms for debt reduction and expansion. This move could restore investor faith in large Indian IPOs. It might set a new standard for future mega listings. The market will watch this development closely.
Sobha shares rocket 10% after Q4 profit soars 124% YoY to Rs 92 crore
Sobha Ltd's shares surged as its Q4 net profit more than doubled to Rs 92 crore, a 124% year-on-year increase. Revenue also climbed 29% to Rs 2,030 crore, driven by strong sales in Bengaluru and NCR. The company highlighted resilient demand for premium housing and a strategic land bank for future growth.
IndiGo ropes in former Airbus executive for AI push
IndiGo has appointed Jochen Hoesch, previously at Airbus, to head its AI, data, and analytics. This move highlights the airline's commitment to enhancing operational efficiency and customer experience through advanced technology. IndiGo is investing in its digital infrastructure to stay future-ready.
Vinay Rajani of HDFC Sec suggests Hero MotoCorp, Oberoi Realty shares to sell in the near-term
The Nifty 50 and Sensex rose on March 16, recovering from a challenging week. However, high crude oil prices amid geopolitical tensions are causing investor caution. Nifty 50 has seen a significant decline recently, raising concerns about future economic stability and investor confidence.
Godrej Properties acquires 11.36 acres in Gurugram for Rs 4,500 crore housing project
Godrej Properties continues its ambitious expansion with the acquisition of an 11.36-acre land in Gurugram, destined for a new residential project that could yield revenues upwards of Rs 4,500 crore. This step into the NCR market enhances their already robust portfolio, ultimately boosting their potential future sales to a remarkable Rs 40,000 crore.
Godrej Properties acquires land in Gurugram, Kolkata; locks in ₹6,150 crore residential project pipeline
Premium projects in Kolkata and Gurugram add over ₹40,000 crore of future sales potential, cementing Godrej Properties' record year for business development.
FS KKR Private Credit Fund Sinks on Dividend Cut, Bad Loans
A private credit fund jointly managed by Future Standard and KKR & Co. plunged after cutting its dividend more than forecast, as earnings declined amid lower interest rates and losses from troubled investments.